Changming Xia - Global Med Affairs, Regeneron Pharmaceut Inc

基本信息

浏览量：0

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 54 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

DUPILUMAB IMPROVES ASTHMA CONTROL AND REDUCES FRACTIONAL EXHALED NITRIC OXIDE AND EXACERBATIONS WITH INHALED CORTICOSTEROID WITHDRAWAL: A PHASE 2 STUDY

MICHAEL E WECHSLER, DAVID JACKSON,KLAUS F RABE,IAN D PAVORD, J C VIRCHOW,ROHIT KATIAL,ELLIOT ISRAEL,CHANGMING XIA,MENA SOLIMAN,NAMI PANDIT-ABID,JUBY A JACOB-NARA,HARRY SACKS,PAUL J ROWE, YAMO DENIZ

CHESTno. 4 (2024): A4779-A4796

引用0浏览0引用

CLINICAL EFFICACY OF DUPILUMAB TREATMENT DURING WITHDRAWAL OF INHALED CORTICOSTEROIDS/LONG-ACTING BETA AGONISTS

MICHAEL E WECHSLER, DAVID JACKSON,KLAUS F RABE,IAN D PAVORD, J C VIRCHOW,ROHIT KATIAL,ELLIOT ISRAEL,CHANGMING XIA,NAMI PANDIT-ABID,MENA SOLIMAN,PAUL J ROWE, YAMO DENIZ,HARRY SACKS,JUBY A JACOB-NARA

CHESTno. 4 (2024): A4761-A4778

引用0浏览0引用

BASELINE CHARACTERISTICS OF PATIENTS ON MEDIUM- VS HIGH-DOSE INHALED CORTICOSTEROIDS IN PATIENTS INITIATING DUPILUMAB IN A REAL-WORLD CLINICAL SETTING: THE RAPID REGISTRY

NJIRA L LUGOGO,ANDRÉANNE CÔTÉ, ARNAUD BOURDIN, ANJU T PETERS,LEONARD B BACHARIER,CHANGMING XIA,NAMI PANDIT-ABID,JUBY A JACOB-NARA,HARRY SACKS,PAUL J ROWE, YAMO DENIZ,MENA SOLIMAN

CHEST（2024）

引用0浏览0引用

Dupilumab Reduces Severe Exacerbations and Improves Lung Function in Patients with Type 2 Asthma Irrespective of Asthma Duration

W. Busse,M. Kraft,C. Domingo Ribas, L. Rogers,I. de Mir,D.J. Maselli,X. Soler,C. Xia,N. Pandit-Abid,J.A. Jacob-Nara,H. Sacks,P.J. Rowe,Y. Deniz

C34 BIOLOGIC THERAPY IN THE FIGHT AGAINST ASTHMA AND ALLERGIC INFLAMMATION (2024)

引用0浏览0引用

Baseline Disease Characteristics among Patients with Chronic Rhinosinusitis with Nasal Polyps and Coexisting Asthma in the Global AROMA Registry

Anju Peters,Enrico Heffler,Tanya Laidlaw,Shigeharu Fujieda,Scott Nash,Changming Xia, Micah Johnson,Lucia De Prado Gomez,Paul Rowe,Yamo Deniz,Juby Jacob-Nara,Harry Sacks

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGYno. 2 (2024): AB211-AB211

引用0浏览0引用

Impact of Early Transient Increase in Eosinophil Count on the Long-term Efficacy of Dupilumab in Patients with Moderate-to-Severe Asthma: Liberty Asthma Traverse

Ian Douglas Pavord,Njira L. Lugogo, Mario Castro,Alberto Papi,Arnaud Bourdin,Michael E. Wechsler,Andréanne Côté,Changming Xia, Mena Soliman,Nami Pandit-Abid,Juby A. Jacob-Nara, Harry Sacks

Airway pharmacology and treatment (2024)

引用0浏览0引用

ASSESSING THE IMPACT OF ASTHMA CONTROL QUESTIONNAIRE SCORE CUTOFFS WITHIN THE MULTICOMPONENT CLINICAL REMISSION ENDPOINT ON CLINICAL OUTCOMES: TRAVERSE OPEN-LABEL STUDY

IAN D PAVORD, ANJU T PETERS,CELESTE PORSBJERG,MARIO CASTRO, J C VIRCHOW,SIMON COUILLARD,CHANGMING XIA,REBECCA GALL,NAMI PANDIT-ABID,PAUL J ROWE, YAMO DENIZ,JUBY A JACOB-NARA,HARRY SACKS

CHESTno. 4 (2024): A4797-A4800

引用0浏览0引用

578. DUPILUMAB EFFICACY IN EOSINOPHILIC OESOPHAGITIS PATIENTS TREATED WITH PRIOR THERAPY AND INADEQUATE RESPONSE, INTOLERANCE, OR CONTRAINDICATION TO SWALLOWED TOPICAL CORTICOSTEROIDS

Antonella Cianferoni,Evan S Dellon,Christoph Schlag,Changming Xia,Sandy Durrani,Tiffany Pela,Amr Radwan,Juby A Jacob-Nara

Diseases of the Esophagusno. Supplement_1 (2024)

引用0浏览0引用

DUPILUMAB PLUS MEDIUM-DOSE INHALED CORTICOSTEROID IMPROVES OUTCOMES COMPARED WITH PLACEBO PLUS HIGH-DOSE INHALED CORTICOSTEROID IN PEDIATRIC PATIENTS WITH UNCONTROLLED ASTHMA

LEONARD B BACHARIER,JORGE F MASPERO,NIKOLAOS PAPADOPOULOS,THERESA GUILBERT,CHANGMING XIA,MENA SOLIMAN,OLIVIER LEDANOIS,PAUL J ROWE, YAMO DENIZ,JUBY A JACOB-NARA,HARRY SACKS

CHESTno. 4 (2024): A4806-A4808

引用0浏览0引用

Efficacité Du Dupilumab Chez Des Patients Avec Et Sans Réduction Minimale Importante De La Fraction De Monoxyde D’azote Dans L’air Expiré Après 2 Semaines

I. Pavord, L. Guilleminault,M. Wechsler,W. Busse,C. Domingo,C. Xia,R. Gall,N. Pandit-Abid,J. Jacob-Nara,A. Radwan,P. Rowe,Y. Deniz

Revue des Maladies Respiratoires Actualitésno. 1 (2024): 186

引用0浏览0引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn